Zurueck zur Suche

Reporte zur Charge U039722

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

21Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
WA 6 CA 6 ID 2 OR 1 NM 1 AZ 1 SD 1 MT 1 VA 1 IL 1

VAERS 2700221

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

mild
Staat
OR
Alter
32,0
Geschlecht
F
Eingang
23.10.2023
Impfdatum
20.10.2023
Beginn
21.10.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site swelling

Symptomtext

Patient reported some redness, pain and swelling around the injection site that developed the day after the injection. She initially thought it was from the bandaid but she did not have the same reaction on the other arm where she also had a bandaid from another injection.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
Unknown
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown. Hepatitis B vaccine was given in the other arm during the same visit.
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2640975

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

mild
Staat
NM
Alter
1,2
Geschlecht
M
Eingang
05.06.2023
Impfdatum
25.05.2023
Beginn
25.05.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Allergy to vaccine Erythema Injection site urticaria Swelling

Symptomtext

Patient developed 2 hives at varicella injection site. Redness resolved but still raised prominently at discharge. Patient discharged home from clinic with prednisolone PO and EpiPen Jr.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site urticaria
Hospital-Tage
-
Labordaten
na
Aktuelle Erkrankungen
na
Vorgeschichte
na
Andere Medikamente
-
Allergien
egg and varicella (after vaccination on 05/25/2023)
Vorherige Impfungen
-

VAERS 2446598

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

mild
Staat
AZ
Alter
1,1
Geschlecht
F
Eingang
15.09.2022
Impfdatum
09.09.2022
Beginn
10.09.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Viral rash

Symptomtext

viral exanthem

Weitere VAERSDATA-Felder
Praegender Schweregrund
Viral rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
-
Andere Medikamente
tylenol
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 2677461

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

gering
Staat
CA
Alter
4,0
Geschlecht
U
Eingang
29.08.2023
Impfdatum
13.06.2023
Beginn
13.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other AE; Improper storage of product in use; This spontaneous report was received from medical assistant and refers to a 4-year-old patient of unknown gender. The patient's medical history and concurrent conditions were not reported. Concomitant medications included sterile diluent. On 13-JUN-2023, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) injection, unk, administered for prophylaxis (strength, and route of administration were not provided), lot #U039722, expiration date: 15-DEC-2023 (discrepancy: lot# reported also as U0397722 and this lot# is not valid for varicella virus vaccine live [oka/merck] [VARIVAX]) (product storage error). Administrated varicella virus vaccine live (oka/merck) (VARIVAX) was stored at 12.45 Fahrenheit degrees (F) for 20 minutes, previous temperature excursion was reported: 42.31 F for 36 hours and 35 minutes. There were no adverse events reported (no adverse event). This is one of several reports received from the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2677460

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

gering
Staat
CA
Alter
12,0
Geschlecht
U
Eingang
29.08.2023
Impfdatum
13.06.2023
Beginn
13.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other AE; Improper storage of product in use; This spontaneous report was received from medical assistant and refers to a 12-year-old patient of unknown gender. The patient's medical history and concurrent conditions were not reported. Concomitant medications included sterile diluent. On 13-JUN-2023, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) injection, unk, administered for prophylaxis (strength, and route of administration were not provided), lot #U039722, expiration date: 15-DEC-2023 (discrepancy: lot# reported also as U0397722 and this lot# is not valid for varicella virus vaccine live [oka/merck] [VARIVAX]) (product storage error). Administrated varicella virus vaccine live (oka/merck) (VARIVAX) was stored at 12.45 Fahrenheit degrees (F) for 20 minutes, previous temperature excursion was reported: 42.31 F for 36 hours and 35 minutes. There were no adverse events reported (no adverse event). This is one of several reports received from the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2677459

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

gering
Staat
CA
Alter
1,2
Geschlecht
U
Eingang
29.08.2023
Impfdatum
17.05.2023
Beginn
17.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other AE; Improper storage of product in use; This spontaneous report was received from medical assistant and refers to a 14-month-old patient of unknown gender. The patient's medical history and concurrent conditions were not reported. Concomitant medications included sterile diluent. On 17-MAY-2023, the patient started was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) injection, unk, administered for prophylaxis (strength, and route of administration were not provided), lot #U039722, expiration date: 15-DEC-2023 (discrepancy: lot# reported also as U0397722 and this lot# is not valid for varicella virus vaccine live [oka/merck] [VARIVAX]) (product storage error). Administrated varicella virus vaccine live (oka/merck) (VARIVAX) was stored at 12.45 Fahrenheit degrees (F) for 20 minutes, previous temperature excursion was reported: 42.31 F for 36 hours and 35 minutes. There were no adverse events reported (no adverse event). This is one of several reports received from the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2677458

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

gering
Staat
CA
Alter
4,0
Geschlecht
U
Eingang
29.08.2023
Impfdatum
17.05.2023
Beginn
17.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other AE; Improper storage of product in use; This spontaneous report was received from medical assistant and refers to a 4-year-old patient of unknown gender. The patient's medical history and concurrent conditions were not reported. Concomitant medications included sterile diluent. On 17-MAY-2023, the patient started was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) injection, unk, administered for prophylaxis (strength, and route of administration were not provided), lot #U039722, expiration date: 15-DEC-2023 (discrepancy: lot# reported also as U0397722 and this lot# is not valid for varicella virus vaccine live [oka/merck] [VARIVAX]) (product storage error). Administrated varicella virus vaccine live (oka/merck) (VARIVAX) was stored at 12.45 Fahrenheit degrees (F) for 20 minutes, previous temperature excursion was reported: 42.31 F for 36 hours and 35 minutes. There were no adverse events reported (no adverse event). This is one of several reports received from the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2676886

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

gering
Staat
CA
Alter
1,3
Geschlecht
U
Eingang
26.08.2023
Impfdatum
08.05.2023
Beginn
08.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other AE; Improper storage of product in use; This spontaneous report was received from medical assistant and refers to a 15-month-old patient of unknown gender. The patient's medical history and concurrent conditions were not reported. Concomitant medications included sterile diluent. On 08-MAY-2023, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) injection, unk, lot #U039722 (lot# reported also as U0397722), expiration date: 15-DEC-2023, administered for prophylaxis (anatomical location, and route of administration were not provided) (product storage error). Administrated varicella virus vaccine live (oka/merck) (VARIVAX) was stored at 12.45 Fahrenheit degrees (F) for 20 minutes, previous temperature excursion was reported: 42.31 F for 36 hours and 35 minutes. There were no adverse events reported (no adverse event). This is one of several reports received from the same reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2652116

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
03.07.2023
Impfdatum
23.06.2023
Beginn
23.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product preparation error

Symptomtext

No additional AE; patient was given VARIVAX product that had been reconstituted with sodium chloride solution instead of sterile diluent.; This spontaneous report has been received from a pharmacist referring to a patient of unknown age or gender. The patient's pertinent medical history, concurrent conditions, concomitant medications and drug reactions or allergies were not reported. On 23-JUN-2023, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) injection (lot# U039722, expiration date 15-DEC-2023, strength, dose, route and anatomical location were not reported) for prophylaxis, which was reconstituted with sodium chloride solution (strength, dose, frequency, lot#, expiration date, route and indication were not reported) instead of sterile diluent (product preparation error). No additional AE details available. No additional AE reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
SODIUM CHLORIDE
Allergien
-
Vorherige Impfungen
-

VAERS 2632104

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

gering
Staat
SD
Alter
1,0
Geschlecht
F
Eingang
15.05.2023
Impfdatum
19.10.2022
Beginn
23.01.2023
Tage bis Beginn
96,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Interchange of vaccine products No adverse event Product administered to patient of inappropriate age

Symptomtext

Denies side effects or symptoms / no additional AE; 1st dose with MMR II and Varivax and 2nd dose with Proquad; PROQUAD second dose prior to age of 4-6 years of age.; This spontaneous report was received from a nurse and refers to a 15-month-old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 19-OCT-2022 (at 12 months old), the patient was vaccinated with the first dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (recombinant human albumin) (M-M-R II) injection, lot #U006489, expiration date reported and confirmed upon internal validation as 26-FEB-2023 (exact dose, frequency, route and site of administration were not reported), and on the same day, she was vaccinated individually with the first dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) injection, lot #U039722, expiration date reported and confirmed upon internal validation as 15-DEC-2023 (exact dose, route and site of administration were not reported), both for prophylaxis. On 23-JAN-2023 (at 15 months old), the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (recombinant human albumin) (PROQUAD) injection, lot #W028564, expiration date reported and confirmed upon internal validation as 06-MAR-2024 (exact dose, frequency, route and site of administration were not reported) as second dose, also for prophylaxis (interchange of vaccine products, product administered to patient of inappropriate age). Side effects or symptoms were denied (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2628147

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

gering
Staat
ID
Alter
18,0
Geschlecht
F
Eingang
02.05.2023
Impfdatum
02.12.2022
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

N/A COVID19 (Pfizer) was not recorded is system, patient didn't bring in any immunization record including COVID19 (white) Card. Extra dose of COVID19 was given.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
No
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
No
Allergien
No
Vorherige Impfungen
-

VAERS 2598079

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

gering
Staat
MT
Alter
1,3
Geschlecht
U
Eingang
17.03.2023
Impfdatum
28.09.2022
Beginn
28.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Laboratory test abnormal Neutropenia Platelet count decreased Thrombocytopenia Wrong product administered

Symptomtext

neutropenia; thombocytopenia/low platelets; Patient's lab work had stopped 'growing and restarted 'growing'.; concomitantly administered STERILE DILUENT Reconstituted PROQUAD instead of the Intended MMRII; Accidental overdose; This spontaneous report was received from a physician referring to a 15-month-old patient of unknown gender. The patient's pertinent medical history, concomitant medications and drug reactions/allergies were not reported. On 28-SEP-2022, the patient was meant to be administered measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection for prophylaxis (strength, dose, lot #, expiration date and route of administration were not provided) but the patient was inadvertently vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection (therapy type: rHA, lot #W004029, expiration date was unknown, but upon internal validation established as: 02-AUG-2023) for prophylaxis (strength, dose and route of administration were not provided) with concomitantly administered sterile diluent (manufacturer unknown) solution for injection/infusion (strength, dose, frequency, indication, lot# and expiration date and route of administration were not provided) instead of the intended measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (wrong product administered). On the same date, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection (lot #U039722, expiration date: 15-DEC-2023) for prophylaxis (dose, strength, and route of administration were not provided) with concomitantly administered sterile diluent (manufacturer unknown) solution for injection/infusion (strength, dose, frequency, indication, lot# and expiration date and route of administration were not provided) (accidental overdose). On unknown dates, the patient's lab work had stopped "growing" and restarted "growing" (laboratory test abnormal). On unknown dates, the patient experienced neutropenia and thombocytopenia/low platelets (thrombocytopenia). The outcome of all events was not reported. The action taken with all suspect therapies was not reported. The causal relationship between all events and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), varicella virus vaccine live (oka/merck) (VARIVAX) and sterile diluent (manufacturer unknown) was not reported. The causal relationship between events of laboratory test abnormal, neutropenia and thrombocytopenia and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was not related. Upon internal review, the events neutropenia and thrombocytopenia were determined to be medically significant.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Laboratory test abnormal
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2557985

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

gering
Staat
VA
Alter
-
Geschlecht
U
Eingang
11.01.2023
Impfdatum
-
Beginn
04.11.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental overdose Incorrect route of product administration No adverse event

Symptomtext

No additional AE details were provided; AThe HCP also reported that both doses were administered intramuscularly instead of subcutaneously; The HCP reports that the patient was inadvertently administered both PROQUAD and VARIVAX at the same time; This spontaneous report has been received from a Medical Assistant, regarding a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies, and concomitant medications were not reported. On 04-NOV-2022, the patient was inadvertently vaccinated with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) subcutaneous injection (lot number: U029323, which was determined to be valid with an expiration date on 19-MAR-2023) and varicella virus vaccine live (Oka/Merck) (VARIVAX) subcutaneous injection (lot number: U039722, which was determined to be valid with an expiration date on 15-DEC-2023); both at a dose of 0.5 milliliters intramuscularly as prophylaxis at the same time (Accidental overdose, Inappropriate route of vaccination). No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental overdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2628144

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

gering
Staat
ID
Alter
17,0
Geschlecht
M
Eingang
05.12.2022
Impfdatum
02.12.2022
Beginn
-
Tage bis Beginn
-
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Circumstance or information capable of leading to medication error Extra dose administered

Symptomtext

N/A COVID19 (Pfizer) and Varivax was not recorded correctly, patient has 3 accounts with first and middle name mixed up, patient didn't bring in any immunization record including COVID19 (white) Card. Extra dose of Covid19 and Varivax were given.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Circumstance or information capable of leading to medication error
Hospital-Tage
-
Labordaten
No
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2386656

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

gering
Staat
WA
Alter
-
Geschlecht
U
Eingang
23.07.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional AE details available; have been stored outside of recommended range; This spontaneous report was received from an office manager in charge of vaccine storage and refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not provided. The concomitant therapies included sterile diluent used for vaccine reconstitution. On an unknown date in2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot # U039722, expiration date 15-DEC-2023 (dose, strength, route of administration and anatomical location were not provided) for prophylaxis (product storage error). The administered vaccine underwent temperature excursion of 6 Fahrenheit degrees up tp 14 Fahrenheit degrees for 50 minutes and 14 Fahrenheit degrees up to 46 Fahrenheit degrees (15 Fahrenheit degrees) for 30 minutes on 28-JUN-2022. There was no previous temperature excursion. No additional adverse event details were available (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2207USA000680:Merck US-009507513-2207USA000470:Merck US-009507513-2207USA000544:Merck US-009507513-2207USA000552:Merck US-009507513-2207USA000563:Merck

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2386655

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

gering
Staat
WA
Alter
-
Geschlecht
U
Eingang
23.07.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE details available; stored outside of recommended range; This spontaneous report was received from an office manager in charge of vaccine storage and refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not provided. The concomitant therapies included sterile diluent used for vaccine reconstitution. On an unknown date in2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot # U039722, expiration date 15-DEC-2023 (dose, strength, route of administration and anatomical location were not provided) for prophylaxis (product storage error). The administered vaccine underwent temperature excursion of 6 Fahrenheit degrees up tp 14 Fahrenheit degrees for 50 minutes and 14 Fahrenheit degrees up to 46 Fahrenheit degrees (15 Fahrenheit degrees) for 30 minutes on 28-JUN-2022. There was no previous temperature excursion. No additional adverse event details were available (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2207USA000544:Merck US-009507513-2207USA000563:Merck US-009507513-2207USA000680:Merck US-009507513-2207USA000470:Merck US-009507513-2207USA000561:Merck

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2372110

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

gering
Staat
WA
Alter
-
Geschlecht
U
Eingang
18.07.2022
Impfdatum
28.06.2022
Beginn
28.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE details available.; 10 total doses of VARIVAX (6 doses) and PROQUAD (4 doses) that have been stored outside of recommended range have been administered to patients; This spontaneous report was received from an office manager in charge of vaccine storage and refer to a patient of unknown age and gender. Concomitant medications included sterile diluent (manufacturer unknown). Pertinent medical history and drug reactions/allergies were not reported. On 28-JUN-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection (lot #U039722, expiration date: 15-DEC-2023), administered for prophylaxis (strength, dose, and route of administration were not provided) (product storage error). It was reported that the suspect vaccine was exposed to a temperature of 6 degree Fahrenheit (F) up to 14 F for 0 hour 50 minutes 0 second; 14 F up to 46 F (15 F) for 0 hour 30 minutes 0 second. There were no previous temperature excursions. No additional adverse event (AE) details were available. This is one of the several report received from the same reporter.; Sender's Comments: US-009507513-2207USA000680: US-009507513-2207USA000470: US-009507513-2207USA000563: US-009507513-2207USA000544:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2371326

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

gering
Staat
WA
Alter
-
Geschlecht
U
Eingang
16.07.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE details available.; have been stored outside of recommended range have been administered to patient; This spontaneous report has been received from the office manager referring a patient of an unknown age and gender. The patient's medical history, concurrent conditions, and previous drug reactions or allergies were not reported. Concomitant medications included sterile diluent. On an unknown date in 2022, reported as between 28-JUN-2022 and 01-JUL-2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX), lot number U039722, expiration date: 15-DEC-2023, as prophylaxis (vaccination scheme, dose, anatomical location and route of administration were not provided) following a temperature excursion of 6 up to 14 Fahrenheit degrees (F) for 0 hours 50 minutes 0 seconds; 14 up to 46 Fahrenheit degrees (F) (15F) for 0 hours 30 minutes 0 seconds, which occurred on 28-JUN-2022 (product storage error). There was stated that no previous temperature excursion occurred. No additional adverse event were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2207USA000680: US-009507513-2207USA000544: US-009507513-2207USA000470: US-009507513-2207USA000552: US-009507513-2207USA000553: US-009507513-2207USA000561: US-009507513-2207USA000765: US-009507513-2207USA000771: US-009507513-2207USA000775:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2371325

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

gering
Staat
WA
Alter
-
Geschlecht
U
Eingang
16.07.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE details available; have been stored outside of recommended range have been administered to patients; This spontaneous report has been received from the office manager referring a patient of an unknown age and gender. The patient's medical history, concurrent conditions, and previous drug reactions or allergies were not reported. Concomitant medications included sterile diluent. On an unknown date in 2022, reported as between 28-JUN-2022 and 01-JUL-2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX), lot number U039722, expiration date: 15-DEC-2023, as prophylaxis (vaccination scheme, dose, anatomical location and route of administration were not provided) following a temperature excursion of 6 up to 14 Fahrenheit degrees (F) for 0 hours 50 minutes 0 seconds; 14 up to 46 Fahrenheit degrees (F) (15F) for 0 hours 30 minutes 0 seconds, which occured on 28-JUN-2022 (product storage error). There was stated that no previous temperature excursion occurred. No additional adverse event were reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2207USA000680: US-009507513-2207USA000470: US-009507513-2207USA000552: US-009507513-2207USA000553: US-009507513-2207USA000561: US-009507513-2207USA000563: US-009507513-2207USA000765: US-009507513-2207USA000771: US-009507513-2207USA000775:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2371323

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

gering
Staat
WA
Alter
-
Geschlecht
U
Eingang
16.07.2022
Impfdatum
28.06.2022
Beginn
28.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional AE details available.; states 10 total doses of VARIVAX (6 doses) and PROQUAD (4 doses) that have been stored outside of recommended range have been administered to patients; This spontaneous report was received from an office manager in charge of vaccine storage and refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not provided. The concomitant therapies included sterile diluent used for vaccine reconstitution. On 28-JUN-2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot # U039722, expiration date 15-DEC-2023 (dose, strength, route of administration and anatomical location were not provided) for prophylaxis (product storage error). The administered vaccine underwent temperature excursion of 6 Fahrenheit degrees up tp 14 Fahrenheit degrees for 50 minutes and 14 Fahrenheit degrees up to 46 Fahrenheit degrees (15 Fahrenheit degrees) for 30 minutes on 28-JUN-2022. There was no previous temperature excursion. No additional adverse event details were available (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2207USA000680: US-009507513-2207USA000544: US-009507513-2207USA000552: US-009507513-2207USA000553: US-009507513-2207USA000561: US-009507513-2207USA000563: US-009507513-2207USA000765: US-009507513-2207USA000771: US-009507513-2207USA000775:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2365776

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U039722

gering
Staat
IL
Alter
-
Geschlecht
F
Eingang
12.07.2022
Impfdatum
15.06.2022
Beginn
15.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE.; expired diluent was used to reconstitute VARIVAX; expired diluent was used to reconstitute VARIVAX and administered to a patient; This spontaneous report was received from a pharmacist and refers to a female patient of unknown age. Concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 15-JUN-2022, expired sterile diluent solution for injection/infusion (lot #T000495, expiration date: 03-JUN-2022) was used to reconstitute varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection (lot #U039722, expiration date: 15-DEC-2023, indication: prophylaxis) and administered to the patient (product preparation issue and expired product administered). Regrading the suspect drug/vaccine, strengths, doses and routes of administration were not reported. Varicella virus vaccine live (oka/merck) (VARIVAX) was not expired, neither product experienced a temperature excursion. No additional AE details provided, no additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Medication dilution
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-